Fresenius Medical Care AG & Co. KGaA
FMS · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $12,853 | $11,286 | $8,950 | $16,724 |
| - Cash | $1,180 | $1,403 | $1,274 | $1,482 |
| + Debt | $11,004 | $12,077 | $13,213 | $13,320 |
| Enterprise Value | $22,677 | $21,960 | $20,889 | $28,563 |
| Revenue | $19,336 | $19,454 | $19,398 | $17,619 |
| % Growth | -0.6% | 0.3% | 10.1% | – |
| Gross Profit | $4,757 | $4,925 | $4,894 | $4,773 |
| % Margin | 24.6% | 25.3% | 25.2% | 27.1% |
| EBITDA | $3,206 | $3,210 | $3,418 | $3,549 |
| % Margin | 16.6% | 16.5% | 17.6% | 20.1% |
| Net Income | $538 | $499 | $673 | $969 |
| % Margin | 2.8% | 2.6% | 3.5% | 5.5% |
| EPS Diluted | 0.92 | 0.85 | 0.57 | 0.83 |
| % Growth | 8.2% | 49.1% | -31.3% | – |
| Operating Cash Flow | $2,386 | $2,629 | $2,167 | $2,489 |
| Capital Expenditures | -$699 | -$685 | -$724 | -$854 |
| Free Cash Flow | $1,687 | $1,944 | $1,443 | $1,635 |